{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:01:02Z","timestamp":1793131262870,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cellsig.2026.112584","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:32:09Z","timestamp":1778340729000},"page":"112584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Caprin-1 silencing reverses YY1\/HSP90\u03b1-mediated IDH1 stabilization to induce ferroptosis and sensitize cervical cancer to cisplatin"],"prefix":"10.1016","volume":"145","author":[{"given":"Tingting","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cellsig.2026.112584_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267571","article-title":"Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis","volume":"17","author":"Tekalign","year":"2022","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112584_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.currproblcancer.2018.01.016","article-title":"Chemotherapy and targeted therapy in the management of cervical cancer","volume":"42","author":"Kumar","year":"2018","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.cellsig.2026.112584_bb0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112584_bb0020","article-title":"Expression of Ferredoxin1 in cisplatin-resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin","author":"Ry\u014dsuke","year":"2023","journal-title":"Oncol. Rep."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112584_bb0025","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2005.10.021","article-title":"Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study","volume":"23","author":"Long","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112584_bb0030","article-title":"The role of iron and reactive oxygen species in cell death","author":"Scott","year":"2013","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112584_bb0035","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2223377","article-title":"LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2\/NAMPT axis","volume":"24","author":"Chen","year":"2023","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cellsig.2026.112584_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114914","article-title":"PFKFB3 confers cisplatin resistance in gastric cancer by inhibiting ferroptosis through SLC7A11\/xCT dephosphorylation","volume":"159","author":"He","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112584_bb0045","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.18632\/oncotarget.3236","article-title":"Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget","volume":"6","author":"Qiu","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112584_bb0050","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bbadis.2013.03.014","article-title":"Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice","volume":"1832","author":"Sabile","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112584_bb0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopha.2013.06.006","article-title":"Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells","volume":"67","author":"Gong","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112584_bb0060","article-title":"Long noncoding RNA ZNFX1-AS1 promotes the invasion and proliferation of gastric cancer cells by regulating LIN28 and CAPR1N1","author":"Zhongling","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112584_bb0065","first-page":"2116","article-title":"Downregulated miR-621 promotes cell proliferation via targeting CAPRIN1 in hepatocellular carcinoma[J]","volume":"8","author":"Yao","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112584_bb0070","article-title":"Retraction note: MicroRNA-199a-5p suppresses the cell growth of colorectal cancer by targeting oncogene Caprin1","author":"Y","year":"2022","journal-title":"3 Biotech"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112584_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28794","article-title":"Cell cycle associated protein 1 associates with immune infiltration and ferroptosis in gastrointestinal cancer","volume":"10","author":"Gao","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112584_bb0080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/bjc.1982.83","article-title":"WHO handbook for reporting results of cancer treatment","volume":"45","author":"PM","year":"1982","journal-title":"Br. J. Cancer"},{"issue":"39","key":"10.1016\/j.cellsig.2026.112584_bb0085","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/s41388-023-02796-2","article-title":"AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression","volume":"42","author":"Wan","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112584_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41389-024-00514-5","article-title":"RIOK3 sustains colorectal cancer cell survival under glucose deprivation via an HSP90\u03b1-dependent pathway","volume":"13","author":"Zhang","year":"2024","journal-title":"Oncogenesis"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112584_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112584_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/00368504221147173","article-title":"Targeting critical pathways in ferroptosis and enhancing antitumor therapy of platinum drugs for colorectal cancer","volume":"106","author":"Wang","year":"2023","journal-title":"Sci. Prog."},{"key":"10.1016\/j.cellsig.2026.112584_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2022.101821","article-title":"Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2\/HO-1 potentiates cisplatin responsiveness in OSCC cells","volume":"64","author":"Han","year":"2022","journal-title":"Mol. Cell. Probes"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112584_bb0110","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41418-022-00998-x","article-title":"Non-coding RNAs and ferroptosis: potential implications for cancer therapy","volume":"29","author":"Balihodzic","year":"2022","journal-title":"Cell Death Differ."},{"issue":"42","key":"10.1016\/j.cellsig.2026.112584_bb0115","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1038\/s41388-018-0360-7","article-title":"Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism","volume":"37","author":"Bai","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112584_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139542","article-title":"Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice","volume":"131","author":"Kadiyala","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"7645","key":"10.1016\/j.cellsig.2026.112584_bb0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112584_bb0130","article-title":"CAPRIN1 enhances chemoresistance and glycolysis in laryngeal squamous cell carcinoma via regulation of ZIC5","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.cellsig.2026.112584_bb0135","doi-asserted-by":"crossref","unstructured":"Yang T, Huang L, Qin H, et al. Stress granule-associated RNA-binding protein CAPRIN1 drives cancer progression and regulates treatment response in nasopharyngeal carcinoma. Med. Oncol., 2022,40(1):47, doi:https:\/\/doi.org\/10.1007\/s12032-022-01910-w, Med. Oncol.","DOI":"10.1007\/s12032-022-01910-w"},{"issue":"47","key":"10.1016\/j.cellsig.2026.112584_bb0140","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.27074","article-title":"Correction: targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget","volume":"10","author":"Qiu","year":"2019","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112584_bb0145","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/1878-0261.13478","article-title":"Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy","volume":"17","author":"Wei","year":"2023","journal-title":"Mol. Oncol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112584_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29092134","article-title":"Stress granule core protein-derived peptides inhibit assembly of stress granules and improve Sorafenib sensitivity in cancer cells","volume":"29","author":"Li","year":"2024","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112584_bb0155","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1158\/2767-9764.CRC-22-0310","article-title":"Identification of membrane-expressed CAPRIN-1 as a novel and universal cancer target, and generation of a therapeutic anti-CAPRIN-1 antibody TRK-950","volume":"3","author":"Okano","year":"2023","journal-title":"Cancer Res. Commun."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:56:58Z","timestamp":1780757818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826002378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0898656826002378"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112584","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caprin-1 silencing reverses YY1\/HSP90\u03b1-mediated IDH1 stabilization to induce ferroptosis and sensitize cervical cancer to cisplatin","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112584"}}